Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Share-based Compensation: 2022-2025

Historic Share-based Compensation for Prokidney (PROK) over the last 4 years, with Sep 2025 value amounting to $6.7 million.

  • Prokidney's Share-based Compensation fell 3.74% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.6 million, marking a year-over-year increase of 65.58%. This contributed to the annual value of $29.4 million for FY2024, which is 4.78% down from last year.
  • Latest data reveals that Prokidney reported Share-based Compensation of $6.7 million as of Q3 2025, which was up 2.06% from $6.5 million recorded in Q2 2025.
  • Over the past 5 years, Prokidney's Share-based Compensation peaked at $52.7 million during Q1 2022, and registered a low of -$6.4 million during Q4 2023.
  • Over the past 3 years, Prokidney's median Share-based Compensation value was $6.9 million (recorded in 2024), while the average stood at $7.3 million.
  • Per our database at Business Quant, Prokidney's Share-based Compensation plummeted by 171.25% in 2023 and then skyrocketed by 209.07% in 2024.
  • Quarterly analysis of 4 years shows Prokidney's Share-based Compensation stood at $8.9 million in 2022, then plummeted by 171.25% to -$6.4 million in 2023, then spiked by 209.07% to $6.9 million in 2024, then dropped by 3.74% to $6.7 million in 2025.
  • Its Share-based Compensation stands at $6.7 million for Q3 2025, versus $6.5 million for Q2 2025 and $6.4 million for Q1 2025.